(Q57739432)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Pramipexole as adjunct to haloperidol in schizophrenia. Safety and efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

Barnas C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Heiden A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Volz HP

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Laakmann G

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Zeit H

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Pfolz H

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

European Neuropsychopharmacology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

65-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

Dopamine autoreceptor agonists in the treatment of schizophrenia and major depression

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Glucose metabolic rate in normals and schizophrenics during the Continuous Performance Test assessed by positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Evidence of Brain Dopamine Deficiency in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Early clinical results with the neuroleptic roxindole (EMD 49,980) in the treatment of schizophrenia--an open study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Reliability and validity of the positive and negative syndrome scale for schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Who are the patients treated in an outpatient clinic with high dosage neuroleptics?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Positive and negative schizophrenic symptoms and the role of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Relevance of Dopamine Autoreceptors for Psychiatry: Preclinical and Clinical Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

B-HT 920, a dopamine D2 agonist, in the treatment of negative symptoms of chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

The effect of the partial dopamine agonist terguride on negative symptoms in schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Schizophrenic Symptoms Improve with Apomorphine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

A10 dopamine neurons: role of autoreceptors in determining firing rate and sensitivity to dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2896%2900393-8

7 January 2021

10.1016/S0924-977X(96)00393-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9088887%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference